Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D + UDCA in PBC
NCT06309589Completed
- Sponsor
- Yilihamu·Abilitifu
- Start
- May 2021
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of vitamin d in primary biliary cholangitis (PBC) (2 arms), sponsored by Yilihamu·Abilitifu. Primary endpoints: UDCA response: Paris I criteria at 1 year and UDCA response: Barcelona criteria at 1 year. Started May 2021; status: completed.
02
Drugs
vitamin d
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT06309589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06309589.